上海深化医改缓解百姓“看病难、看病贵”

2019-07-22 佚名 新华社

今年,上海将在全市布局58个医疗服务圈,计划用3年左右时间,建设一批布局合理、标准统一、定位清晰的区域医疗中心,让老百姓在家门口就能配好药、看好病。

记者在上海采访了解到,开展省级综合医改试点3年来,上海强化制度创新和政策保障,做社区综合医改的“先行者”,啃公立医院改革的“硬骨头”,下“真功夫”强保障、控费用,通过医疗、医保、医药“三医联动”积极有效缓解“看病难、看病贵”。

在医疗服务资源配置中,上海坚持向社区下沉,向老年护理、康复、儿科、急救等薄弱环节倾斜。全市夯实基层网底,创新“1+1+1”医疗机构组合签约机制,居民可自愿选择一名社区卫生服务中心家庭医生、一家区级医院、一家市级医院签约;平均每月为家庭医生优先预留13.8万个门诊号源,坚持以更优质的服务和更优惠的政策引导市民基层首诊,截至2019年7月15日签约居民已超700万人,组合内就诊率达71%。

同时,上海加大二、三级医院帮扶社区力度,大力推动区域医疗中心和专科医联体建设。居民在社区检查、一小时内就可以拿到市或区级医院影像专家出具的报告,这在许多医联体内已经成为常态。

今年,上海将在全市布局58个医疗服务圈,计划用3年左右时间,建设一批布局合理、标准统一、定位清晰的区域医疗中心,让老百姓在家门口就能配好药、看好病,缓解中心城区大医院人满为患和看专家排长队问题;继续推进区域和专科医联体建设,重点推进“新华-崇明”紧密型区域医联体建设惠及岛上居民。

牢牢守住公益性,坚持社会效益最大化,上海全面加强公立医院党建工作,在绩效考核、收入分配等关键环节动真格,积极探索专业化、精细化、规范化的现代医院管理制度。今年,上海有6家医院纳入建立健全现代医院管理制度国家试点,并将进一步完善公立医院医疗服务评价机制。

在严格监管、医药分开,切断医务人员考核、收入分配与科室经济收入之间直接挂钩等举措下,上海公立医院医疗费用增幅连续明显下降。今年,上海将通过技术手段,建立公立医院监管评价云管理平台等,对医疗费用进行实时监测,对费用有明显不合理增长的医院开展督导和约谈。

上海在健全药品保障机制、挤压药价“水分”上也“重磅”连连:完善医药采购“阳光平台”,加强对药品和医疗器械采购、配送、使用的全流程监管;探索部分高价药品谈判采购机制,将国家谈判药品和部分肿瘤分子靶向药纳入医保目录,开展抗癌药品专项集中采购……

在遏制医药费用攀升的同时,上海积极完善基本医保制度,稳步提升市民基本医保待遇,降低政策范围内个人自付费用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664678, encodeId=1a6216646e8ce, content=<a href='/topic/show?id=faf9e2628ff' target=_blank style='color:#2F92EE;'>#看病难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72628, encryptionId=faf9e2628ff, topicName=看病难)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfbb25811672, createdName=12498ca5m91暂无昵称, createdTime=Sat Jul 04 09:12:00 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969784, encodeId=3d5d1969e84d4, content=<a href='/topic/show?id=a0c0e262689' target=_blank style='color:#2F92EE;'>#看病贵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72626, encryptionId=a0c0e262689, topicName=看病贵)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Jul 01 01:12:00 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775866, encodeId=b8c41e7586636, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Fri Sep 27 13:12:00 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287107, encodeId=2b98128e10773, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Wed Jul 24 11:12:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664678, encodeId=1a6216646e8ce, content=<a href='/topic/show?id=faf9e2628ff' target=_blank style='color:#2F92EE;'>#看病难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72628, encryptionId=faf9e2628ff, topicName=看病难)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfbb25811672, createdName=12498ca5m91暂无昵称, createdTime=Sat Jul 04 09:12:00 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969784, encodeId=3d5d1969e84d4, content=<a href='/topic/show?id=a0c0e262689' target=_blank style='color:#2F92EE;'>#看病贵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72626, encryptionId=a0c0e262689, topicName=看病贵)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Jul 01 01:12:00 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775866, encodeId=b8c41e7586636, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Fri Sep 27 13:12:00 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287107, encodeId=2b98128e10773, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Wed Jul 24 11:12:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
    2020-07-01 wetgdt
  3. [GetPortalCommentsPageByObjectIdResponse(id=1664678, encodeId=1a6216646e8ce, content=<a href='/topic/show?id=faf9e2628ff' target=_blank style='color:#2F92EE;'>#看病难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72628, encryptionId=faf9e2628ff, topicName=看病难)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfbb25811672, createdName=12498ca5m91暂无昵称, createdTime=Sat Jul 04 09:12:00 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969784, encodeId=3d5d1969e84d4, content=<a href='/topic/show?id=a0c0e262689' target=_blank style='color:#2F92EE;'>#看病贵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72626, encryptionId=a0c0e262689, topicName=看病贵)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Jul 01 01:12:00 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775866, encodeId=b8c41e7586636, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Fri Sep 27 13:12:00 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287107, encodeId=2b98128e10773, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Wed Jul 24 11:12:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664678, encodeId=1a6216646e8ce, content=<a href='/topic/show?id=faf9e2628ff' target=_blank style='color:#2F92EE;'>#看病难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72628, encryptionId=faf9e2628ff, topicName=看病难)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfbb25811672, createdName=12498ca5m91暂无昵称, createdTime=Sat Jul 04 09:12:00 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969784, encodeId=3d5d1969e84d4, content=<a href='/topic/show?id=a0c0e262689' target=_blank style='color:#2F92EE;'>#看病贵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72626, encryptionId=a0c0e262689, topicName=看病贵)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Jul 01 01:12:00 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775866, encodeId=b8c41e7586636, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Fri Sep 27 13:12:00 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287107, encodeId=2b98128e10773, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Wed Jul 24 11:12:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
    2019-07-24 tidiq

相关资讯

国务院办公厅发布2019医改重点任务:推进药品集中采购试点

今日(6月4日),国务院办公厅正式发布《深化医药卫生体制改革2019年重点工作任务》的通知,以下为原文: 深化医药卫生体制改革2019年重点工作任务 2019年深化医药卫生体制改革工作要以习近平新时代中国特色社会主义思想为指导,全面贯彻党的十九大和十九届二中、三中全会精神,认真落实党中央、国务院关于实施健康中国战略和深化医药卫生体制改革的决策部署,坚持以人民健康为中心,坚持保基本、强基

DRG付费模式下谁是赢家?

国家医保局、财政部、国家卫生健康委、国家中医药局发布关于印发按疾病诊断相关分组付费国家试点城市名单的通知。通知指出,国家DRG付费国家试点工作组根据前期各省(区、市)申报参加DRG付费国家试点的情况,确定北京、天津、上海等30个城市作为DRG付费国家试点城市。 医保资金捉襟见肘已经不是新闻了,国家这次出台DRG也是为了指导临床医生合理用药,改善用药结构,提高诊疗质量,更有效率的利用医保资金。

上海医改再放大招!医疗技术负面清单出炉

近日,上海市卫健委印发《上海市医疗技术临床应用管理办法实施细则》的通知,公布了限制类医疗技术负面清单目录。

医改再提速!北京3700家医院将取消医用耗材加成

6月15日起,北京市将启动医耗联动综合改革,3700家医疗机构同步取消医用耗材加成,同时开展国家药品集中采购试点、实行京津冀医用耗材联合采购,以及规范调整医疗服务项目价格等配套改革。 北京市卫生健康委主任雷海潮说,此次改革的主要内容可概述为一降低、一提升、一取消、一采购和一改善。“一降低”,是指降低仪器设备开展的检验项目价格;“一提升”,是指提升中医、病理、精神、康复、手术等体现医务人员劳动

县域医疗大变局!500个紧密型县域医共体试点呼之欲出 附指导方案

最新数据显示,全国已组建3000余个县域医疗共同体。《指导方案》明确13项医共体建设工作内容。

BMJ:北大学者医改系列文章:卫生支出GDP占比从5%增至6.4%,自付费用降至30%以下

近期,北京大学学者在BMJ发表系列文章,分析了我国卫生体制改革的成就和挑战。